Gilead Sciences (GILD) PT Raised to $165 at Wells Fargo

February 11, 2026 8:27 AM

Wells Fargo analyst Mohit Bansal raised the price target on Gilead Sciences (NASDAQ: GILD) to $165.00 (from $150.00) while maintaining a Overweight rating.

No results found